PSG9 Antikörper (Middle Region)
Kurzübersicht für PSG9 Antikörper (Middle Region) (ABIN954352)
Target
Alle PSG9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody recognizes Human PSG9 / PSG11 (Center).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected from the Central region of human PSG9
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PSG9 (Pregnancy Specific beta-1-Glycoprotein 9 (PSG9))
-
Andere Bezeichnung
- PSG9 / PSG11
-
Hintergrund
- Synonyms: PS-beta-B, PS-beta-G-11, PS34, PSBG-11, PSBG-9, PSG7, Pregnancy-, Pregnancy-specific beta-1 glycoprotein B, Pregnancy-specific beta-1-glycoprotein 11, Pregnancy-specific glycoprotein 11, Pregnancy-specific glycoprotein 7, Pregnancy-specific glycoprotein 9
-
Molekulargewicht
- 48272 Da
-
Gen-ID
- 5678
-
NCBI Accession
- NP_002775
Target
-